Enzymotec to Report Third Quarter 2015 Financial Results
2015年10月29日 - 5:05AM
Enzymotec Ltd. (NASDAQ:ENZY), a developer, manufacturer and
marketer of innovative bio-active lipid ingredients, today
announced that the Company will release financial results for the
third quarter ended September 30, 2015 on Wednesday, November 11,
2015, before the market opens. Following the release, Dr. Ariel
Katz, President and Chief Executive Officer, and Oren Bryan, Vice
President and Chief Financial Officer, will host a conference call
to review the financial results.
The conference call is scheduled to begin at 8:30 a.m. ET on
Wednesday, November 11, 2015. Participants should dial (877)
359-9508 (United States) or (224) 357-2393 (International) with
confirmation code 68587231 to access the live call. The call will
also be broadcast live over the Internet, hosted in the Investors
section of Enzymotec's website
at http://edge.media-server.com/m/p/8pq5hbsy, and will be
archived online within one hour of its completion through November
18, 2015.
About Enzymotec Ltd.
Enzymotec Ltd. is a leading global supplier of specialty
lipid-based products and solutions. The Company develops,
manufactures and markets innovative bio-active lipid ingredients,
as well as final products, based on sophisticated processes and
technologies. For more information,
visit www.enzymotec.com.
CONTACT: The Ruth Group
Tram Bui / Lee Roth
(646) 536-7035/7012
tbui@theruthgroup.com
lroth@theruthgroup.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
過去 株価チャート
から 6 2024 まで 7 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (ナスダック市場): 0 recent articles
その他のニュース記事